İlgili Haberler
Ashwin backs unchanged India XI for 4th T20I vs England, despite Samson calls
Former India spinner Ravichandran Ashwin advocates for an unchanged playing XI in the fourth T20I against England, emphasizing stability despite Sanju Samson's omission and the team's poor form. Ashwin believes this approach sends a strong message and fosters security within the squad, even if Samson misses out again.
Australia to Return Three Ancient Indian Artefacts to India
Australia announced the return of three ancient Indian artefacts: a trident of Goddess Bhadrakali, a Nandi idol, and a six-headed Kartikeya idol. This reciprocal gesture follows India's agreement to repatriate ancestral remains of an Australian First Nations individual.
UK Man Found Guilty of Raping and Killing Estranged Wife
Michael Thompson, 56, has been convicted of murdering and raping his estranged wife, Kimberley Thompson, 43, in their shared UK home. Jurors at Nottingham Crown Court found him guilty after a six-week trial, rejecting his claims of suicide and finding evidence of prolonged abuse.
Emirati Stunt Performer Brings Authentic Desert Action to 'Dune: Part Three'
Emirati stunt performer Mohammed F. Mostafa is bringing authentic desert action to 'Dune: Part Three', filmed in Abu Dhabi's Liwa Desert. The film highlights UAE talent and its growing film industry on the global stage.

क्या ओटीटी कंटेंट पर सेंसर बोर्ड की निगरानी होती है, फ़िल्म 'सतलुज' पर हुए विवाद से समझिए
अभिनेता दिलजीत दोसांझ की फ़िल्म 'सतलुज' को 3 जुलाई 2026 को ज़ी5 पर रिलीज़ किया गया, लेकिन 5 जुलाई को भारत में हटा दिया गया. ओटीटी पर सेंसर बोर्ड की निगरानी नहीं होती, यह आईटी रूल्स 2021 के तहत आता है. फ़िल्म हटाने के कारण स्पष्ट नहीं हैं, पर यह अनौपचारिक दबाव का मामला हो सकता है.
India Launches Awiqli, World's First Once-Weekly Basal Insulin
India has introduced Awiqli, the world's first once-weekly basal insulin, offering a new treatment for its over 101 million adults with diabetes. Developed by Novo Nordisk, Awiqli simplifies therapy by reducing injections from 365 to 52 annually, providing comparable blood sugar control to daily insulins.